Presentation TCT 2016 Severe AS and COPD Presenter: Howard C. Herrmann, Vinod H. Thourani, Kendra J. Grubb October 31, 2016
Presentation TCT 2016 Low-gradient AS Diagnosis and Management Presenter: Howard C. Herrmann, Vinod H. Thourani, Allan Schwartz October 31, 2016
Presentation TCT 2016 Severe AS With a Small Aortic Annulus Presenter: Howard C. Herrmann, Vinod H. Thourani, Josep Rodés-Cabau October 31, 2016
Presentation TCT 2016 Severe AS and LV Dysfunction Presenter: Howard C. Herrmann, Vinod H. Thourani, G. Michael Deeb October 31, 2016
News Conference News TCT 2016 Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field? Todd Neale October 30, 2016
Presentation TCT 2016 Key Contributions to TAVR Clinical Research VI: Updates From the NOTION Randomized All-Comers Trial Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Lars Sondergaard October 30, 2016
Presentation TCT 2016 Key Contributions to TAVR Clinical Research V: Updates From U.S. TVT Registry Newest Findings Presenter: Jeffrey J. Popma, E. Murat Tuzcu, John D. Carroll October 30, 2016
Presentation TCT 2016 Key Contributions to TAVR Clinical Research IV: Updates From FRANCE 2 Registry Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Helene Eltchaninoff October 30, 2016
Presentation TCT 2016 Valve-in-Valve Therapies - Not Just a Russian Doll! Technical and Clinical Challenges: Clinical Updates Presenter: Carlos E. Ruiz, Ulrich Steinseifer, Danny Dvir October 30, 2016
Presentation TCT 2016 Key Contributions to TAVR Clinical Research III: Updates From Italian Registries and OBSERVANT Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Corrado Tamburino October 30, 2016
Presentation TCT 2016 Aortic Stenosis + Concomitant Disease III. TAVR in Patients With Atrial Fibrillation - Outcomes, Adjunctive Pharmacology, and Accessory Therapies (Including LAA Closure) Presenter: A. Pieter Kappetein, Allan Schwartz, Samir R. Kapadia October 30, 2016
Presentation TCT 2016 What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? Stop Wasting Valuable Time Go Straight to LVAD/Transplant! Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Nir Uriel October 30, 2016
Presentation TCT 2016 Valve-in-Valve Therapies - Not Just a Russian Doll! Technical and Clinical Challenges: Engineering Perspectives Presenter: Carlos E. Ruiz, Ulrich Steinseifer, Ajit Yoganathan October 30, 2016
Presentation TCT 2016 Key Contributions to TAVR Clinical Research II: Updates From the UK TAVR Registry Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Neil E. Moat October 30, 2016
Presentation TCT 2016 What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? MitraClip Should Always Be Considered First! Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Saibal Kar October 30, 2016
Presentation TCT 2016 Key Contributions to TAVR Clinical Research I: Updates From GARY and Other German Registries Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Thomas Walther October 30, 2016
Presentation TCT 2016 Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat Presenter: A. Pieter Kappetein, Allan Schwartz, James B. Hermiller Jr. October 30, 2016
Presentation TCT 2016 Update on RCTs in FMR, and First Report of the COAPT Roll-in Patients Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Gregg W. Stone October 30, 2016
Presentation TCT 2016 Paravalvular Regurgitation - The Achilles Hell or Problem Solved: Better Assessment of PVL on the Bench - Recommendations by the ISO Cardiac Valves Committee Presenter: Carlos E. Ruiz, Ulrich Steinseifer, Neelakantan Saikrishnan October 30, 2016
Presentation TCT 2016 Aortic Stenosis + Concomitant Disease I. TAVR in Patients With Mitral Regurgitation - Outcomes and Management Strategies (Including MitraClip) Presenter: A. Pieter Kappetein, Allan Schwartz, Marco Barbanti October 30, 2016